Two Sigma Advisers’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.49M | Buy |
41,700
+5,800
| +16% | +$347K | 0.01% | 1013 |
|
2025
Q1 | $1.88M | Sell |
35,900
-1,100
| -3% | -$57.7K | ﹤0.01% | 1178 |
|
2024
Q4 | $2.04M | Sell |
37,000
-13,100
| -26% | -$721K | ﹤0.01% | 1116 |
|
2024
Q3 | $2.52M | Sell |
50,100
-800
| -2% | -$40.2K | 0.01% | 964 |
|
2024
Q2 | $2.24M | Buy |
50,900
+19,400
| +62% | +$852K | 0.01% | 1127 |
|
2024
Q1 | $1.39M | Buy |
31,500
+1,800
| +6% | +$79.2K | ﹤0.01% | 1410 |
|
2023
Q4 | $1.41M | Sell |
29,700
-4,200
| -12% | -$199K | ﹤0.01% | 1466 |
|
2023
Q3 | $1.5M | Buy |
33,900
+8,800
| +35% | +$390K | ﹤0.01% | 1340 |
|
2023
Q2 | $1.2M | Buy |
25,100
+8,900
| +55% | +$425K | ﹤0.01% | 1466 |
|
2023
Q1 | $637K | Sell |
16,200
-1,200
| -7% | -$47.2K | ﹤0.01% | 1842 |
|
2022
Q4 | $492K | Sell |
17,400
-700
| -4% | -$19.8K | ﹤0.01% | 1882 |
|
2022
Q3 | $544K | Sell |
18,100
-10,300
| -36% | -$310K | ﹤0.01% | 1810 |
|
2022
Q2 | $964K | Sell |
28,400
-7,400
| -21% | -$251K | ﹤0.01% | 1614 |
|
2022
Q1 | $1.61M | Buy |
35,800
+4,000
| +13% | +$179K | ﹤0.01% | 1380 |
|
2021
Q4 | $1.47M | Buy |
31,800
+15,000
| +89% | +$693K | ﹤0.01% | 1350 |
|
2021
Q3 | $564K | Buy |
+16,800
| New | +$564K | ﹤0.01% | 1877 |
|
2019
Q3 | – | Sell |
-12,300
| Closed | -$252K | – | 2305 |
|
2019
Q2 | $252K | Sell |
12,300
-2,300
| -16% | -$47.1K | ﹤0.01% | 2071 |
|
2019
Q1 | $410K | Buy |
14,600
+2,000
| +16% | +$56.2K | ﹤0.01% | 1866 |
|
2018
Q4 | $308K | Sell |
12,600
-200
| -2% | -$4.89K | ﹤0.01% | 1971 |
|
2018
Q3 | $476K | Buy |
+12,800
| New | +$476K | ﹤0.01% | 1813 |
|